Lawmakers said they cannot evaluate the effectiveness of the administration’s initiative to lower prescription drug prices until the relevant contracts are released.
Also Read
- Iranian President Brands U.S. and Israel Aggressors in Defiant U.N. Address
- Sa’ar rejects claim of global consensus against Israel, says UN majority cannot dictate policy
- U.S. Drug Certification: A Law Enforcement Tool or Political Leverage?
- Zelensky Calls on World Leaders to Keep Russian Revenue Streams in Crosshairs at UN